Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bevacizumab use in disseminated choroid plexus papilloma.

Literature DB >> 23761024

Bevacizumab use in disseminated choroid plexus papilloma.

Mark Daniel Anderson, Brett J Theeler, Marta Penas-Prado, Morris D Groves, W K Alfred Yung.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2013 PMID： 23761024 DOI： 10.1007/s11060-013-1180-9

Source DB: PubMed Journal: J Neurooncol ISSN： 0167-594X Impact factor: 4.130

× No keyword cloud information.

7 in total

1. Diffuse leptomeningeal seeding from benign choroid plexus papilloma.

Authors: M Ortega-Martínez; J M Cabezudo-Artero; I Fernández-Portales; J J Pimentel; R Gómez de Tejada
Journal: Acta Neurochir (Wien) Date: 2007-10-10 Impact factor: 2.216

2. Spinal deposits of a benign choroid plexus papilloma.

Authors: H Akil; N J Coupe; J Singh
Journal: J Clin Neurosci Date: 2008-04-11 Impact factor: 1.961

3. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.

Authors: Scott R Plotkin; Anat O Stemmer-Rachamimov; Fred G Barker; Chris Halpin; Timothy P Padera; Alex Tyrrell; A Gregory Sorensen; Rakesh K Jain; Emmanuelle di Tomaso
Journal: N Engl J Med Date: 2009-07-08 Impact factor: 91.245

Review 4. Choroid plexus papillomas: advances in molecular biology and understanding of tumorigenesis.

Authors: Michael Safaee; Michael C Oh; Orin Bloch; Matthew Z Sun; Gurvinder Kaur; Kurtis I Auguste; Tarik Tihan; Andrew T Parsa
Journal: Neuro Oncol Date: 2012-11-21 Impact factor: 12.300

5. Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors.

Authors: Mark W Kieran; Jeffrey G Supko; Dana Wallace; Robert Fruscio; Tina Young Poussaint; Peter Phillips; Ian Pollack; Roger Packer; James M Boyett; Susan Blaney; Anu Banerjee; Russ Geyer; Henry Friedman; Stewart Goldman; Larry E Kun; Tobey Macdonald
Journal: Pediatr Blood Cancer Date: 2009-02 Impact factor: 3.167

6. Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 study.

Authors: Brigitte Wrede; Martin Hasselblatt; Ove Peters; Peter F Thall; Tezer Kutluk; Albert Moghrabi; Anita Mahajan; Stefan Rutkowski; Blanca Diez; Xuemei Wang; Torsten Pietsch; Rolf-Dieter Kortmann; Werner Paulus; Astrid Jeibmann; Johannes E A Wolff
Journal: J Neurooncol Date: 2009-06-20 Impact factor: 4.130

7. VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma.

Authors: Arindel S R Maharaj; Tony E Walshe; Magali Saint-Geniez; Shivalingappa Venkatesha; Angel E Maldonado; Nathan C Himes; Kabir S Matharu; S Ananth Karumanchi; Patricia A D'Amore
Journal: J Exp Med Date: 2008-02-11 Impact factor: 14.307

7 in total

4 in total

Bevacizumab use in disseminated choroid plexus papilloma.

1. Diffuse leptomeningeal seeding from benign choroid plexus papilloma.

2. Spinal deposits of a benign choroid plexus papilloma.

3. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.

Review 4. Choroid plexus papillomas: advances in molecular biology and understanding of tumorigenesis.

5. Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors.

6. Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 study.

7. VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma.

1. Bevacizumab in progressive disseminated atypical choroid plexus papilloma in adults.

2. Delayed Recurrence of Choroid Plexus Carcinoma in the Sacral Spinal Cord 17 Years after Its Initial Presentation.

3. Leptomeningeal dissemination of low-grade neuroepithelial CNS tumors in adults: a 15-year experience.

4. Suboccipital Craniotomy and C1 Laminectomy for Atypical Choroid Plexus Papilloma.